CVR number 41727659
Industry 21.1000 Manufacture of basic pharmaceutical products

Real Canna Denmark A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2018
N/A
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 13.7% 14.3%  
Credit score (0-100)  0 0 0 15 14  
Credit rating  N/A N/A N/A B B  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
N/A
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 -2,427 -4,004  
EBITDA  0.0 0.0 0.0 -4,983 -5,228  
EBIT  0.0 0.0 0.0 -4,983 -5,228  
Pre-tax profit (PTP)  0.0 0.0 0.0 -5,004.4 -5,247.3  
Net earnings  0.0 0.0 0.0 -5,004.4 -3,272.2  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -5,004 -5,247  
 
See the entire income statement

Balance sheet (kDKK) 
2018
N/A
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
Tangible assets total  0.0 0.0 0.0 217 217  
Shareholders equity total  0.0 0.0 0.0 -6,014 -8,927  
Interest-bearing liabilities  0.0 0.0 0.0 7,000 7,951  
Balance sheet total (assets)  0.0 0.0 0.0 3,321 2,628  
Net Debt  0.0 0.0 0.0 6,519 7,945  
 
See the entire balance sheet

Volume 
2018
N/A
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 -2,427 -4,004  
Gross profit growth  0.0% 0.0% 0.0% 0.0% -65.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 3,321 2,628  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% -20.9%  
Added value  0.0 0.0 0.0 -4,983.1 -5,227.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 217 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 -2.0  

Profitability 
2018
N/A
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 205.3% 130.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -53.4% -50.0%  
ROI %  0.0% 0.0% 0.0% -71.2% -69.9%  
ROE %  0.0% 0.0% 0.0% -150.7% -110.0%  

Solidity 
2018
N/A
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
Equity ratio %  0.0% 0.0% 0.0% -64.4% -77.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -130.8% -152.0%  
Gearing %  0.0% 0.0% 0.0% -116.4% -89.1%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.6% 0.3%  

Liquidity 
2018
N/A
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
Quick Ratio  0.0 0.0 0.0 0.3 0.2  
Current Ratio  0.0 0.0 0.0 0.3 0.2  
Cash and cash equivalent  0.0 0.0 0.0 481.2 6.0  

Capital use efficiency 
2018
N/A
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -6,231.7 -9,143.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
N/A
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0